# Aldosterone Blockade in Chronic Kidney Disease: Influence on Arterial Stiffness and Kidney Function

> **NCT01100203** · PHASE3 · TERMINATED · sponsor: **Lene Boesby** · enrollment: 54 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** Eplerenone

## Key facts

- **NCT ID:** NCT01100203
- **Lead sponsor:** Lene Boesby
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-04
- **Primary completion:** 2012-01
- **Final completion:** 2012-02
- **Target enrollment:** 54 (ACTUAL)
- **Why stopped:** It was not possible within the time frame to recruit the planned no. of patients.
- **Last updated:** 2012-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01100203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01100203, "Aldosterone Blockade in Chronic Kidney Disease: Influence on Arterial Stiffness and Kidney Function". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01100203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*